Emergent BioSolutions Is Looking Stronger

Here's an update on EBS shares.

Danaher Could Trade Higher

I do not find enough technical reasons to recommend new long positions at this point in time.

Here's Why Eli Lilly Broke to the Upside

Let's review the charts and indicators.

2 Small-Caps Still Worth Considering in This Red-Hot Market

Oncology concern Exelixis and biopharma Ardelyx offer reasons to believe their shares should rise in the months ahead.

How to Play Emergent BioSolutions Right Now

A correction in EBS could soon set up an attractive opportunity.

The Week That Was, Q4 Earnings Expectations, Key Investor and Healthcare Events

This Friday several banks begin the unofficial kickoff of 'earnings season'.

This Dividend Aristocrat Would Be a Noble Addition to Your Portfolio

The company's size and scale are nearly unmatched in its sector.

Here's My Biotech Pick for 2021

But know first that to really succeed in the sector, diversifying is key.

CVS Health's Charts Are Close to an Important Breakout

Aggressive traders could go long CVS at current levels.

AbbVie Is a Stock to Position for 2021

Let's review the charts and indicators.